IL-22BP attenuates right ventricular remodeling in pulmonary arterial hypertension
Clinical Science · 15.07.2026 · 140 (7) · 1575-1597
DOI: 10.1042/cs20260392 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Science, online erschienen am 03.07.2026. Verfasst von Han Feng und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, The Second Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Ventricular Remodeling, Receptors, Interleukin, Pulmonary Arterial Hypertension, Hypertrophy, Right Ventricular. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0). Gefördert von: Key Project of Health Commission of Jiangsu Province, National Natural Science Foundation of China, Key Project of the Jiangsu Geriatrics Society.
Abstract (Originalsprache)
Pulmonary arterial hypertension (PAH) is a progressive cardiopulmonary disease in which right ventricular (RV) dysfunction and remodeling are major determinants of poor prognosis. Interleukin-22 binding protein (IL-22BP), encoded by IL22RA2/Il22ra2, is an endogenous antagonist of IL-22, but its role in PAH-associated RV remodeling remains unclear. Here, we investigated whether IL-22BP regulates RV remodeling through the IL-22/STAT3 axis. Serum IL-22BP levels were reduced in patients with PAH. In experimental PAH, RV IL-22BP was decreased in Sugen5416/hypoxia (SuHx) and monocrotaline rat models, and both RV Il22ra2 mRNA and IL-22BP protein were reduced in SuHx mice. In the SuHx mouse model, systemic Il22ra2 deficiency aggravated PAH severity and RV remodeling, accompanied by enhanced RV IL-22/IL-22R1/STAT3 signaling and increased remodeling-associated transcripts related to hypertrophy, fibrosis, apoptosis, and proliferation. Conversely, AAV-mediated IL-22BP reconstitution with preferential cardiac expression attenuated RV hypertrophy and dysfunction and suppressed RV IL-22/STAT3 signaling. Pharmacological STAT3 inhibition with S3I-201 partially rescued the aggravated PAH and RV remodeling phenotype in SuHx-treated Il22ra2−/− mice. Complementary H9C2 cell experiments showed that IL-22 enhanced Ang II-associated STAT3 activation and remodeling-related transcriptional responses, whereas S3I-201 attenuated several Ang II-induced remodeling signals. Lung analysis showed altered pulmonary IL-22/STAT3 signaling after SuHx exposure and Il22ra2 deficiency, but cardiac IL-22BP reconstitution did not significantly normalize these whole-lung markers. Th17-related immune changes paralleled disease severity and IL-22BP-associated improvement. Finally, treprostinil plus oridonin produced broader phenotypic improvement than either monotherapy and increased cardiac IL-22BP expression. These findings identify IL-22BP as a treatment-responsive endogenous regulator of PAH-associated RV remodeling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatrics, The Second Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.
- Key Laboratory for Aging & Disease, Nanjing Medical University, Nanjing, Jiangsu, China.
- School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, China.
- Department of Cardiovascular Surgery, Zhongda Hospital, Southeast University, Nanjing, Jiangsu, China.
- School of Pediatrics, Nanjing Medical University, Nanjing, Jiangsu, China.
ORCID-Profile: Zhengxia Liu
Förderung
- Key Project of Health Commission of Jiangsu Province
- National Natural Science Foundation of China
- Key Project of the Jiangsu Geriatrics Society
- Natural Science Foundation of Jiangsu Province
- Jiangsu Provincial Key Research Project on Geriatric Health
Zitieren
APA
Feng, H., Liu, Y., Hu, W., Zou, J., Lu, C., Zeng, W., Yang, J., Tao, X., Zhou, P., Zhang, J., Qu, C., He, W., & Liu, Z. (2026). IL-22BP attenuates right ventricular remodeling in pulmonary arterial hypertension. Clinical Science, 140(7), 1575-1597. https://doi.org/10.1042/cs20260392
Vancouver
Feng H, Liu Y, Hu W, Zou J, Lu C, Zeng W, et al. IL-22BP attenuates right ventricular remodeling in pulmonary arterial hypertension. Clinical Science. 2026;140(7):1575-1597. doi:10.1042/cs20260392
BibTeX
@article{Feng2026,
author = {Feng, Han and Liu, Ying and Hu, Wenhui and Zou, Jiahui and Lu, Chen and Zeng, Wei and Yang, Jiahui and Tao, Xinyu and Zhou, Ping and Zhang, Juan and Qu, Chen and He, Wei and Liu, Zhengxia},
title = {IL-22BP attenuates right ventricular remodeling in pulmonary arterial hypertension},
journal = {Clinical Science},
year = {2026},
volume = {140},
number = {7},
pages = {1575--1597},
doi = {10.1042/cs20260392}
}
EUVIMED